Cusano of Cummings Properties signs enEvolv to 10,000 s/f lease

January 12, 2018 - Front Section

Medford, MA enEvolv, a biotechnology firm, will open a new and larger laboratory and research office. The 10,000 s/f space is located at 200 Boston Ave., a commercial building operated by Cummings Properties. It will replace enEvolv’s former facility on Morrissey Blvd. in Boston. 

“Boston Ave. is a great location for biotech firms because it’s close to research and academic institutions like Tufts and MIT,” said Cummings leasing officer Steve Cusano, who worked on the transaction with Ellen Cullinan of Freudenheim Partners. “In addition, it’s close enough to the city to offer public transportation and many area amenities, but client firms also benefit from free parking as well as leasing rates that are a third lower than those typically found in nearby Cambridge.”

Steve Cusano, Cummings Properties


Ellen Cullinan, Freudenheim Partners


“enEvolv is expanding, and this new location offers the company a larger first-class laboratory that it can grow into,” said Cullinan.

enEvolv joins other leaders in life sciences and technology that have offices within Cummings Properties’ Boston Ave.  portfolio, located near I-93 and Rtes. 2, 3, and 60.

Cummings Properties’ portfolio of 11 million s/f of prime space accommodates offices, healthcare facilities, labs, restaurants, retail storefronts, warehouses, co-working spaces, executive suites, and more. With a portfolio of this size and variety, the firm can meet almost any commercial real estate need from 150 square feet to 300,000 square feet. Its in-house experts in design, construction, and property management offer “one-stop shopping” for leasing clients.

enEvolv works with pharmaceutical, nutrition, energy, and specialty chemical companies to engineer microbes and produce bio-based chemicals. The company’s strain engineering platform combines biotechnology with automation to identify the changes in genomes that produce specific results, such as preventing genetically modified organisms from escaping and thriving in the wild. Its co-founder, renowned geneticist George Church, has appeared in media outlets from The Washington Post to “The Late Show with Stephen Colbert.”



Add Comment